Medicare Enrolled

Dr. Bao Nguyen, D.O.

Name: Federal CMS public records for Dr. Bao Nguyen (NPI 1861848061)
Creator: U.S. Centers for Medicare & Medicaid Services
License: https://www.usa.gov/government-works

Cardiovascular Disease · Longview, TX

Research-focused

703 E MARSHALL AVE STE 5007, Longview, TX 75601

9033154882

In practice since 2016 (9 years)

NPI: 1861848061 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Nguyen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Nguyen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nguyen

Dr. Bao Nguyen is a cardiovascular disease in Longview, TX, with 9 years in practice.

Between the years covered by Open Payments, Dr. Nguyen received a total of $62,373 from 22 pharmaceutical and/or device companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nguyen is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice$ $62,373 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$62,373

Total received (2018-2024)

Avg $8,910/year across 7 years

Top 9% in TX for cardiovascular disease

Companies

269

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research

Research funding and grants

$38,984 (62.5%)

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$23,094 (37.0%)

Speaking / Promotional

Speaker programs, honoraria, and industry-sponsored educational events

$295 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$1,357

2023

$44,957

2022

$10,616

2021

$4,054

2020

$413

2019

$843

2018

$132

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

Abbott Laboratories

$31,795

Medtronic, Inc.

$11,147

BIOTRONIK INC.

$10,244

Boston Scientific Corporation

$5,281

Biosense Webster, Inc.

$838

Philips Electronics North America Corporation

$686

ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)

$432

Amgen Inc.

$424

BOSTON SCIENTIFIC CORPORATION

$312

ABIOMED

$210

Gilead Sciences, Inc.

$132

ZOLL Circulation Inc

$129

Inari Medical, Inc.

$129

Kiniksa Pharmaceuticals, Ltd.

$122

Janssen Pharmaceuticals, Inc

$107

E.R. Squibb & Sons, L.L.C.

$104

Lantheus Medical Imaging, Inc.

$98

PFIZER INC.

$86

Salix Pharmaceuticals, a division of Bausch Health US, LLC

$42

Kiniksa Pharmaceuticals International, plc

$21

AstraZeneca Pharmaceuticals LP

$19

Novartis Pharmaceuticals Corporation

$16

Top 3 companies account for 85.3% of total payments

Associated products mentioned in payments ›

(9124) LM Undivided · ACCOLADE · ACCOLADE SR · ADVANTIO · ALTRUA · ALTRUA 20 · AMPLIA MRI QUAD CRT-D SURESCAN · AMVIA EDGE · ATTAIN COMMAND + SUREVALVE · Acticor · Acticor 7 VR-T DX · Arcalyst · BIOMONITOR · BRILINTA · BioMonitor · CARTO 3 · Carto 3 · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · ESSENTIO SR · Edora · Edora 8 DR-T · EnSite Precision Cardiac Mapping System · Epclusa · FLOWTRIEVER CATHETER · GENERAL BRADY · GENERAL EP · GENERAL TACHY · GENERAL VASCULAR INTERVENTION · GENERAL - THERAPIES · General - Brady · General - Therapies · Impella · LifeVest · MICRA · NUVISION ICE CATHETER · OCTARAY MAPPING CATHETER · Plexa ProMRI · QDOT MICRO Catheter · Quadra Assura CRT Defibrillator · RESONATE · RHYTHMIA · Renamic Neo · Repatha · Rivacor · S · Selectra · Sentus · Solia · TherOx DS2 Console · VALITUDE · VISITAG SURPOINT External Processing Unit · VYNDAQEL · XARELTO · XIFAXAN

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 9% for cardiovascular disease in TX.

Looking for a cardiovascular disease in Longview?
Compare cardiovascular diseases in the Longview area by procedure volume, costs, and industry payment transparency.

Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi

Per 100K population

8.0

County median income

$64,809

Nearest hospital

CHRISTUS GOOD SHEPHERD MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	✓ PECOS	Monthly updates
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nguyen is a cardiovascular disease, and high industry engagement (research-focused, top 9%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Nguyen receive payments from pharmaceutical companies?

Yes. Dr. Nguyen received a total of $62,373 from 22 companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Nguyen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city

Cardiovascular Diseases in Longview

Browse cardiovascular diseases in Longview ranked by procedure volume and transparency data.

Highest volume

Top Cardiovascular Diseases in TX

Cardiovascular Diseases ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Cardiovascular Diseases in TX

Which TX cardiovascular diseases receive the most from drug and device companies.

By company

Abbott Laboratories Payments to Doctors

See all physicians who received payments from Abbott Laboratories.

By company

Medtronic, Inc. Payments to Doctors

See all physicians who received payments from Medtronic, Inc..

By company

BIOTRONIK INC. Payments to Doctors

See all physicians who received payments from BIOTRONIK INC..

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology